Clinical Trials Directory

Trials / Unknown

UnknownNCT02179593

Effectiveness of SARPE With 3 and 2-Segment Technique: A Randomized Clinical Trial

Effectiveness of Surgically Assisted Rapid Palatal Expansion (SARPE) With 3 and 2-Segment Technique: A Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
17 Years – 50 Years
Healthy volunteers
Not accepted

Summary

A few studies state that 3-segment SARPE has the following advantages: a) higher level of expansion symmetry; b) higher level of stability of the expansion achieved; and c) faster bone healing. The investigators hypothesize that 2-segment SARPE is as effective as 3-segment SARPE concerning treatment and/or quality of life in daily practice.

Detailed description

32 healthy, literate adult patients (male and female) with 7-millimeter transverse maxilla deficiency bilaterally distributed will participate in this study. The participants will be assigned randomizable in equal number to undergo either 3-segment or 2-segment SARPE. Individuals that a) have undergone maxilla surgery previously; b) have craniofacial anomaly;and c) have dental crowding will not be enrolled. All participants will be assessed before and after surgery for sensitivity to pressure and temperature in the innervated structures linked to the maxilla, as well as for quality of life using OHIP-49 and B-OQLQ assessment tools. The expansion of maxilla will be assessed by superimposing tomographic images before and after surgery.

Conditions

Interventions

TypeNameDescription
OTHER2-Segment SARPELe Fort I osteotomy with oppening of the median palatal suture and SARPE.
OTHER3-Segment SARPELe Fort I osteotomy with two parallel osteotomies symetrically positioned with reference to the median palatal suture and SARPE.

Timeline

Start date
2013-09-01
Primary completion
2016-08-01
Completion
2016-12-01
First posted
2014-07-02
Last updated
2016-03-16

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02179593. Inclusion in this directory is not an endorsement.